By Emma Gallegos
Daily Journal Staff Writer
A false advertising spat in federal court between competing California companies that manufacture hyperbaric chambers could have unintended consequences - highlighting the questionable marketing practices of an industry that thrives largely outside the purview of the U.S. Food and Drug Administration.
Hyperbaric chambers are large, pressurized units that increase the flow of oxygen, a...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In